Yuqian Yan
Mayo Clinic(US)Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine(CN)Neurological Surgery(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Protein Degradation and Inhibitors, FOXO transcription factor regulation
Most-Cited Works
- → Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation(2017)299 cited
- → RAD21 Mutations Cause a Human Cohesinopathy(2012)267 cited
- → Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression(2018)261 cited
- → DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4(2018)171 cited
- → Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG(2021)115 cited
- → Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers(2011)104 cited